standards@synzeal.com +91-7969-225-400 WhatsApp : +91-6357-003-635
Register |
whatapp-icon
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Infigratinib-D3 - Request Quote

Picture of Infigratinib-D3

Infigratinib-D3

SZ CAT No: SZ-I065D01
CAS No
NA
Mol.F.
C26H28D3Cl2N7O3
Mol.Wt.
563.5
Inv. Status
Synthesis on demand
Need help?
Product Overview Description Technical Data

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Infigratinib-D3 is chemically 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-(methyl-d3)urea. Infigratinib-D3 is supplied with detailed characterization data compliant with regulatory guideline. Infigratinib-D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Infigratinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Infigratinib-D3

Purchase Infigratinib-D3

Infigratinib-D3 suppliers

Infigratinib-D3 manufacturers

Infigratinib-D3 price

Order Infigratinib-D3

Enquire Infigratinib-D3

Infigratinib-D3 cost

Infigratinib-D3 Supplier

Infigratinib-D3 Distributor

Infigratinib-D3 for Method Validation

Infigratinib Reference Standard

Infigratinib-D3 for ANDA Filing

Infigratinib-D3 for Forced Degradation Studies

Infigratinib-D3 Identification Standards

Infigratinib-D3 for DMF Filing

Related Products

Picture of Infigratinib
  • copy-icon-new
  • cart-icon

Infigratinib

  • SZ CAT No: SZ-I065001
  • CAS No:
    872511-34-7
  • Mol.F.: C26H31Cl2N7O3
  • Mol.Wt.: 560.5
  • Inv. Status: Synthesis on demand
  • Rel. CAS No: 1310746-15-6 (HCl salt) ; 1310746-11-2 (hydrate salt) ; 1310746-22-5 (HBr salt)
Picture of Infigratinib N-Oxide Impurity
  • copy-icon-new
  • cart-icon

Infigratinib N-Oxide Impurity

  • SZ CAT No: SZ-I065002
  • CAS No:
    NA
  • Mol.F.: C26H31Cl2N7O4
  • Mol.Wt.: 576.5
  • Inv. Status: Under Synthesis
Picture of Infigratinib Impurity 1
  • copy-icon-new
  • cart-icon

Infigratinib Impurity 1

  • SZ CAT No: SZ-I065003
  • CAS No:
    115619-00-6
  • Mol.F.: C12H17N3O2
  • Mol.Wt.: 235.3
  • Inv. Status: Synthesis on demand
Picture of Infigratinib Impurity 2
  • copy-icon-new
  • cart-icon

Infigratinib Impurity 2

  • SZ CAT No: SZ-I065004
  • CAS No:
    79257-61-7
  • Mol.F.: C10H13NO3
  • Mol.Wt.: 195.2
  • Inv. Status: Synthesis on demand
Picture of Infigratinib Impurity 3
  • copy-icon-new
  • cart-icon

Infigratinib Impurity 3

  • SZ CAT No: SZ-I065005
  • CAS No:
    943189-21-7
  • Mol.F.: C10H11Cl2NO3
  • Mol.Wt.: 264.1
  • Inv. Status: Synthesis on demand
Picture of Infigratinib Impurity 4
  • copy-icon-new
  • cart-icon

Infigratinib Impurity 4

  • SZ CAT No: SZ-I065006
  • CAS No:
    75177-59-2
  • Mol.F.: C9H8Cl2O4
  • Mol.Wt.: 251.1
  • Inv. Status: Synthesis on demand
Picture of Infigratinib Impurity 5
  • copy-icon-new
  • cart-icon

Infigratinib Impurity 5

  • SZ CAT No: SZ-I065007
  • CAS No:
    2607108-25-6
  • Mol.F.: C9H9Cl2NO4
  • Mol.Wt.: 266.1
  • Inv. Status: Synthesis on demand
Picture of N-Nitroso Infigratinib
  • copy-icon-new
  • cart-icon

N-Nitroso Infigratinib

  • SZ CAT No: SZ-I065008
  • CAS No:
    NA
  • Mol.F.: C26H30Cl2N8O4
  • Mol.Wt.: 589.5
  • Inv. Status: Synthesis on demand
Picture of Infigratinib-D3
  • copy-icon-new
  • cart-icon

Infigratinib-D3

  • SZ CAT No: SZ-I065D01
  • CAS No:
    NA
  • Mol.F.: C26H28D3Cl2N7O3
  • Mol.Wt.: 563.5
  • Inv. Status: Synthesis on demand
ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

Notice

Date:

Location: